Literature DB >> 11586198

Quantification of 5-aminolevulinic acid induced fluorescence improves the specificity of bladder cancer detection.

D Zaak1, D Frimberger, H Stepp, S Wagner, R Baumgartner, P Schneede, M Siebels, R Knüchel, M Kriegmair, A Hofstetter.   

Abstract

PURPOSE: 5-Aminolevulinic acid induced fluorescence endoscopy has outstanding sensitivity for detecting early stage bladder cancer. Nevertheless, a third of the lesions that show specific fluorescence are histologically benign. We decreased the false-positive rate of 5-aminolevulinic acid induced fluorescence endoscopy by incorporating protoporphyrin IX fluorescence quantification into the standard cystoscopy procedure.
MATERIALS AND METHODS: In 25 cases (53 biopsies) of a history of or suspicion for bladder cancer 5-aminolevulinic acid induced fluorescence endoscopy and fluorescence image quantification were performed. For fluorescence image quantification images obtained with a target integrating color charge-coupled device camera were digitized and stored in a personal computer. Red-to-blue ratios were calculated from fluorescence positive lesions and results were correlated with hematoxylin and eosin histology.
RESULTS: Malignant fluorescence positive lesions showed significantly stronger fluorescence intensity than fluorescing lesions with benign histology. A threshold was established that decreased the false-positive rate by 30% without affecting sensitivity.
CONCLUSIONS: Fluorescence image quantification is a new endoscopic method for objectively selecting multicolor fluorescence bladder lesion images for biopsy. It has the potential of eliminating human error by different surgeons with variable experience in fluorescence endoscopy.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11586198

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  5 in total

Review 1.  Chemoprevention of bladder cancer.

Authors:  Dragan J Golijanin; David Kakiashvili; Ralph R Madeb; Edward M Messing; Seth P Lerner
Journal:  World J Urol       Date:  2006-11       Impact factor: 4.226

2.  Preferential accumulation of 5-aminolevulinic acid-induced protoporphyrin IX in breast cancer: a comprehensive study on six breast cell lines with varying phenotypes.

Authors:  Stacy R Millon; Julie H Ostrander; Siavash Yazdanfar; J Quincy Brown; Janelle E Bender; Anita Rajeha; Nirmala Ramanujam
Journal:  J Biomed Opt       Date:  2010 Jan-Feb       Impact factor: 3.170

3.  Recommendations for the improvement of bladder cancer quality of care in Canada: A consensus document reviewed and endorsed by Bladder Cancer Canada (BCC), Canadian Urologic Oncology Group (CUOG), and Canadian Urological Association (CUA), December 2015.

Authors:  Wassim Kassouf; Armen Aprikian; Peter Black; Girish Kulkarni; Jonathan Izawa; Libni Eapen; Adrian Fairey; Alan So; Scott North; Ricardo Rendon; Srikala S Sridhar; Tarik Alam; Fadi Brimo; Normand Blais; Chris Booth; Joseph Chin; Peter Chung; Darrel Drachenberg; Yves Fradet; Michael Jewett; Ron Moore; Chris Morash; Bobby Shayegan; Geoffrey Gotto; Neil Fleshner; Fred Saad; D Robert Siemens
Journal:  Can Urol Assoc J       Date:  2016-02-08       Impact factor: 1.862

Review 4.  [Fluorescence cystoscopy at bladder cancer: present trials].

Authors:  D Zaak; A Karl; H Stepp; S Tritschler; D Tilki; M Burger; R Knuechel; C Stief
Journal:  Urologe A       Date:  2007-11       Impact factor: 0.639

Review 5.  New frontier in hypericin-mediated diagnosis of cancer with current optical technologies.

Authors:  Malini Olivo; Chit Yaw Fu; Vijaya Raghavan; Weber Kam On Lau
Journal:  Ann Biomed Eng       Date:  2011-11-29       Impact factor: 3.934

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.